Jonathan K. Embleton
Corporate Officer/Principal presso Amerigen Pharmaceuticals Ltd.
Profilo
Jonathan K.
Embleton is a professional who has worked in various pharmaceutical companies.
He is currently the Chief Business Officer at Amerigen Pharmaceuticals Ltd.
Prior to this, he worked as a Vice President at Cardinal Health, Inc., a Principal at R.P.
Scherer Corp., and a Vice President-Product Ventures at Catalent Pharma Solutions, Inc. Embleton received his undergraduate and doctorate degrees from the University of Aston.
Posizioni attive di Jonathan K. Embleton
| Società | Posizione | Inizio |
|---|---|---|
Amerigen Pharmaceuticals Ltd.
 Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Corporate Officer/Principal | 01/01/2010 |
Precedenti posizioni note di Jonathan K. Embleton
| Società | Posizione | Fine |
|---|---|---|
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
| CATALENT PHARMA SOLUTIONS, INC. | Corporate Officer/Principal | - |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
Formazione di Jonathan K. Embleton
| University of Aston | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| Aziende private | 3 |
|---|---|
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Health Technology |
Amerigen Pharmaceuticals Ltd.
Amerigen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Amerigen Pharmaceuticals Ltd. engages in the development, manufacturing, and sale of generic pharmaceutical products. The company was founded in 2007 and is headquartered in Lyndhurst, NJ. | Health Technology |
R.P. Scherer Corp.
 R.P. Scherer Corp. Pharmaceuticals: MajorHealth Technology R.P. Scherer Corp. Develops and manufactures oral drug delivery systems. The company offers different types of medical services and products. It has approximately 4 medical faculties in United States. The company is located in Troy, MI | Health Technology |
- Borsa valori
- Insiders
- Jonathan K. Embleton
